Aureobasidium pullulans-cultured fluid induces IL-18 production, leading to Th1-polarization during influenza A virus infection

Several microbial molecules with pathogen-associated molecular patterns stimulate host innate immune responses. The innate immune system plays a crucial role in activating acquired immune response via cytokine production and antigen presentation. Previous studies have shown that Aureobasidium pullulans-cultured fluid (AP-CF), which contains β-glucan, exhibits adjuvant activity and renders mice resistance to influenza A virus infection; however, the underlying mechanism remains elusive. In this study, we investigated the innate immune response to AP-CF. We found that intraperitoneal administration of AP-CF increased the serum level of IL-18 and the number of splenic IFN-γ producing CD4+ cells during influenza A virus infection. The adjuvant effect of AP-CF was distinct from that of alum, which is known to have the ability to stimulate a Th2 immune response. In addition, AP-CF injection barely increased the number of peritoneal neutrophils and inflammatory macrophages, whereas alum injection markedly increased the number of neutrophils and inflammatory macrophages, suggesting that AP-CF is a weak inducer of inflammation compared to alum. AP-CF induced IL-18 production by DC2.4 cells, a dendritic cell line, and by peritoneal exudate cells that include peritoneal macrophages. Collectively, our findings indicate that AP-CF is an adjuvant that promotes the Th1 response during influenza A virus infection.

[1]  H. Sugiyama,et al.  Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy , 2016, Oncoimmunology.

[2]  N. Maeda,et al.  Oral administration of the Aureobasidium pullulans-derived β-glucan effectively prevents the development of high fat diet-induced fatty liver in mice , 2015, Scientific Reports.

[3]  C. Borg,et al.  Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine , 2015, Vaccines.

[4]  L. Brown,et al.  Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2Cys , 2015, Front. Immunol..

[5]  A. Iwasaki,et al.  Control of adaptive immunity by the innate immune system , 2015, Nature Immunology.

[6]  H. Shime,et al.  Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo , 2015, Nature Communications.

[7]  G. Rimmelzwaan,et al.  Virus-specific T cells as correlate of (cross-)protective immunity against influenza. , 2015, Vaccine.

[8]  H. Kida,et al.  Stimulation with the Aureobasidium pullulans-produced β-glucan effectively induces interferon stimulated genes in macrophage-like cell lines , 2014, Scientific Reports.

[9]  C. Coban,et al.  Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist , 2014, Proceedings of the National Academy of Sciences.

[10]  G. Randolph,et al.  Local apoptosis mediates clearance of macrophages from resolving inflammation in mice. , 2013, Blood.

[11]  J. Kolls,et al.  T cell-mediated host immune defenses in the lung. , 2013, Annual review of immunology.

[12]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[13]  S. Akira,et al.  Type-I Interferon is Critical for FasL Expression on Lung Cells to Determine the Severity of Influenza , 2013, PloS one.

[14]  Harm HogenEsch,et al.  Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants , 2013, Front. Immun..

[15]  J. McVernon,et al.  Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice. , 2012, Molecular pharmaceutics.

[16]  A. Iwai,et al.  β-Glucan Derived from Aureobasidium pullulans Is Effective for the Prevention of Influenza in Mice , 2012, PloS one.

[17]  C. Coban,et al.  DNA released from dying host cells mediates aluminum adjuvant activity , 2011, Nature Medicine.

[18]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[19]  Jun Ma,et al.  Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse” , 2011, Nature.

[20]  Y. Adachi,et al.  Induction of IFN-γ by a highly branched 1,3-β-d-glucan from Aureobasidium pullulans in mouse-derived splenocytes via dectin-1-independent pathways. , 2011, Biochemical and biophysical research communications.

[21]  U. Hasler,et al.  Osmoprotective Transcription Factor NFAT5/TonEBP Modulates Nuclear Factor-κB Activity , 2010, Molecular biology of the cell.

[22]  Y. Adachi,et al.  A highly branched 1,3-beta-D-glucan extracted from Aureobasidium pullulans induces cytokine production in DBA/2 mouse-derived splenocytes. , 2009, International immunopharmacology.

[23]  Y. Adachi,et al.  Structural characterisation and biological activities of a unique type β-d-glucan obtained from Aureobasidium pullulans , 2008, Glycoconjugate Journal.

[24]  T. Onaka,et al.  Immunological Actions of Sophy β‐Glucan (β‐1,3‐1,6 Glucan), Currently Available Commercially as a Health Food Supplement , 2007 .

[25]  L. Brown,et al.  Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines. , 2006, International immunology.

[26]  Toshio Suzuki,et al.  Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast. , 2006, Anticancer research.

[27]  T. Akazawa,et al.  Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies , 2006, Evidence-based complementary and alternative medicine : eCAM.

[28]  R. Flavell,et al.  Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.

[29]  Corey Smith,et al.  A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Akira,et al.  IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. , 1998, Journal of immunology.

[31]  S. Akira,et al.  Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.

[32]  F. Finkelman,et al.  Cytokine-mediated regulation of chronic intestinal helminth infection , 1994, The Journal of experimental medicine.

[33]  A. Levine,et al.  Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. , 1979, Cancer research.

[34]  W. Stinebring,et al.  Toxic Properties of a Synthetic Double-stranded RNA: Endotoxin-like Properties of Poly I.Poly C, an Interferon Stimulator , 1969, Nature.

[35]  T. Onaka,et al.  Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement. , 2007, Microbiology and immunology.